Tamanho do Mercado, Tendências e Relatório de Crescimento de Terapêutica de Ácidos Nucleicos, Aditivos Alimentares Esportivos e Cuidados com a Pele na América do Norte em 2032.

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

Tamanho do mercado em biliões de dólares

CAGR : 7.14 %

USD 5.50 Billion USD 9.54 Billion 2024 2032

Período de previsão	2025 –2032
Tamanho do mercado (ano base )	USD 5.50 Billion
Tamanho do mercado ( Ano de previsão)	USD 9.54 Billion
CAGR	7.14 %
Principais participantes do mercado	Pfizer Inc. Biogen Alnylam Pharmaceuticals Inc. Ionis Pharmaceuticals Inc. AstraZeneca

Segmentação do mercado de ácido nucleico terapêutico, aditivos alimentares para desporto e cuidados com a pele na América do Norte, por produto (ácido nucleico terapêutico, produtos de ácido nucleico para cuidados com a pele e aditivos alimentares de ácido nucleico para desporto), fonte (ácidos nucleicos naturais e ácidos nucleicos sintéticos), utilizador final (consumidores individuais/saúde domiciliária e utilização profissional/em instalações), canal de distribuição (licitação direta, vendas a retalho e outros) - tendências do setor e previsão até 2032

Tamanho do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

O mercado norte-americano de produtos terapêuticos de ácido nucleico, aditivos alimentares desportivos e cuidados com a pele foi avaliado em 5,50 mil milhões de dólares em 2024 e prevê-se que atinja os 9,54 mil milhões de dólares até 2032.
Durante o período previsto de 2025 a 2032, o mercado deverá crescer a um CAGR de 7,14%, impulsionado principalmente pela crescente procura de alimentos funcionais, nutracêuticos e ingredientes bioativos para o cuidado da pele.
Este crescimento é impulsionado por fatores como a crescente influência da medicina personalizada e de soluções personalizadas para o cuidado da pele, políticas regulamentares favoráveis e crescentes investimentos em I&D em terapias baseadas em genes.

Análise de mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

O mercado das terapias com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele deverá crescer significativamente devido à crescente consciencialização sobre a saúde, ao maior foco no bem-estar personalizado e aos avanços na biotecnologia e na investigação dermatológica.
Os consumidores procuram cada vez mais produtos que promovam a saúde celular, o desempenho físico e o rejuvenescimento da pele, impulsionando a procura nestes segmentos
O mercado está a assistir a uma rápida inovação, incluindo terapias direcionadas baseadas em genes, produtos de nutrição desportiva funcional e formulações bioativas para o cuidado da pele, que estão a aumentar a eficácia e a expandir as ofertas de produtos.
Estas inovações estão a atrair tanto profissionais de saúde como consumidores que procuram soluções com base científica e orientadas para resultados.

Âmbito do Relatório e Segmentação do Mercado de Terapêutica com Ácido Nucleico, Aditivos Alimentares Desportivos e Cuidados com a Pele

Atributos	Insights sobre o mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele
Segmentos abrangidos	Subproduto: Ácido Nucleico Terapêutico, Produtos para o Cuidado da Pele com Ácido Nucleico e Aditivos Alimentares Desportivos com Ácido Nucleico Por fonte: Ácidos Nucleicos Naturais e Ácidos Nucleicos Sintéticos Por utilizador final: consumidores individuais/assistência médica domiciliária e utilização profissional/em instalações Por canal de distribuição: concurso direto, vendas a retalho e outros
Países abrangidos	América do Norte PIOLHO Canadá México
Principais participantes do mercado	Pfizer Inc. (EUA) Biogen (EUA) Alnylam Pharmaceuticals, Inc. (EUA) Sarepta Therapeutics, Inc. (EUA) (EUA) AstraZeneca (Reino Unido) Modern, Inc. (LOUSE) Novartis AG (Suíça) Spark Therapeutics, Inc. (EUA) Tecnologia Biofarmacêutica Zhejiang Haichang Co., Ltd. (China) Remy Laure (França) NOVO (EUA) MoonGlow (Ucrânia) The Naked Chemist (Nova Zelândia) SKINSHIFT (EUA) Bio Jouvance Paris Consumidor (EUA) Instituto DNA Skin (EUA) Juliette Armand (Grécia) Kalichem srl (Itália) NIPPON PAPER INDUSTRIES CO., LTD. (Japão) PostQuam (Espanha) Shopatdna.com (Índia)
Oportunidades de mercado	Avanços nas terapias baseadas em RNA e DNA, aditivos alimentares e inovações nos cuidados da pele Expansão através de parcerias e colaborações estratégicas
Conjuntos de informações de dados de valor acrescentado	Para além dos insights sobre os cenários de mercado, tais como o valor de mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os principais participantes, os relatórios de mercado selecionados pela Data Bridge Market Research incluem também a análise de importação e exportação, a visão geral da capacidade de produção, a análise do consumo da produção, a análise da tendência dos preços, o cenário das alterações climáticas, a análise da cadeia de abastecimento, a análise da cadeia de valor, a visão geral da matéria-prima/consumíveis, os critérios de seleção de fornecedores, a análise PESTLE, a análise de Porter e a estrutura regulamentar.

Tendências do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

“Convergência de Biotecnologia, Bem-Estar Personalizado e Soluções de Beleza Limpa”

Inovações como tratamentos baseados em mRNA, terapias de silenciamento de genes e formulações de cuidados da pele personalizadas por ADN estão a revolucionar a forma como os indivíduos gerem a saúde, otimizam o desempenho físico e abordam as condições da pele a nível molecular.
- Por exemplo, os produtos de cuidados da pele à base de ácidos nucleicos estão a ser adaptados aos perfis genéticos individuais, permitindo regimes personalizados que abordam preocupações específicas como o envelhecimento, a pigmentação e a inflamação.
No espaço da nutrição desportiva, os aditivos de rótulo limpo e apoiados pela ciência estão a ganhar força, impulsionados pela procura de recuperação muscular melhorada, desempenho cognitivo e reparação celular — geralmente apoiados por dados genómicos

Dinâmica do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Motorista

“Crescente procura por alimentos funcionais, nutracêuticos e ingredientes bioativos para o cuidado da pele”

À medida que os consumidores se tornam mais preocupados com a saúde, procuram cada vez mais produtos que ofereçam mais do que nutrição básica — produtos que possam melhorar a função metabólica, melhorar a recuperação e apoiar a saúde imunitária.
No setor alimentar, os alimentos funcionais que proporcionam benefícios específicos para a saúde, como uma melhor digestão, uma melhor função cognitiva e uma recuperação muscular melhorada, estão a tornar-se uma tendência significativa.
Os alimentos funcionais baseados em RNA e DNA são particularmente notáveis, com os avanços nestes campos a permitirem abordagens mais personalizadas à nutrição. Estes ingredientes bioativos não só melhoram a saúde geral, como também apoiam intervenções de saúde mais direcionadas com base em predisposições genéticas.
- Por exemplo, em janeiro de 2021, um artigo publicado pela Biblioteca Nacional de Medicina destacou a crescente utilização de compostos bioativos nos alimentos e nos cuidados com a pele, enfatizando o seu potencial para melhorar a saúde metabólica, a imunidade e a regeneração da pele. Realça a crescente importância dos ingredientes funcionais no tratamento de problemas de saúde relacionados com a idade e na otimização do bem-estar geral.
- Por exemplo, em novembro de 2021, a Elsevier BV publicou um artigo onde discute os avanços nos nutracêuticos, com especial enfoque nos ingredientes baseados em RNA e DNA que melhoram as funções metabólicas e suportam o microbioma intestinal.
Estes avanços estão a mudar as preferências dos consumidores para produtos que oferecem mais do que apenas nutrição básica, atendendo à procura de soluções de saúde personalizadas.
A crescente procura por alimentos funcionais, nutracêuticos e cuidados bioativos da pele está a impulsionar a inovação para soluções personalizadas e com suporte científico. As tecnologias baseadas em RNA e DNA estão a permitir produtos mais direcionados que melhoram o metabolismo, a recuperação muscular e a saúde da pele

Oportunidade

“Avanços nas terapias baseadas em RNA e DNA, aditivos alimentares e inovações nos cuidados da pele”

Os avanços nas tecnologias baseadas em RNA e DNA estão a abrir novas fronteiras. Na terapêutica, as vacinas de mRNA e as ferramentas de edição genética, como o CRISPR, revolucionaram a medicina, oferecendo potenciais curas para doenças genéticas, cancros e infeções virais.
Nos cuidados com a pele, as formulações baseadas em ADN e ARN estão a transformar os tratamentos antienvelhecimento e de reparação da pele. O ADN derivado de organismos marinhos, peptídeos de RNA e exossomas estão a ser incorporados em produtos de cuidados da pele de alta qualidade para promover a renovação celular, reparar a pele danificada e combater os stressores ambientais.
O aumento dos diagnósticos de cuidados da pele baseados em genes fortalece ainda mais a procura, permitindo regimes de cuidados da pele personalizados, adaptados ao perfil genético de cada indivíduo.
Estas inovações estão alinhadas com as tendências de beleza limpa e cosméticos baseados na biotecnologia, aumentando as oportunidades para os cosmecêuticos premium.

Por exemplo,

Em janeiro de 2023, de acordo com a Springer Nature Limited, a tecnologia de edição genética CRISPR/Cas9 está a progredir no tratamento de doenças genéticas, corrigindo mutações prejudiciais ou desativando genes causadores de doenças.

Destaca melhorias nos métodos de edição genética, sistemas de administração e abordagens de tratamento, enfatizando a importância de escolher as técnicas certas para diferentes doenças e garantir uma aplicação segura e eficaz.
em agosto de 2023, de acordo com a Elsevier BV, o estudo destaca os avanços nas terapias baseadas em RNA e ADN, particularmente a edição do genoma CRISPR/Cas9, que permite modificações precisas do ADN para tratar distúrbios genéticos. Os avanços na terapêutica baseada em mRNA melhoram ainda mais o tratamento de doenças, melhorando a eficácia e os resultados dos doentes na terapia genética e na medicina regenerativa

A integração de inovações baseadas em RNA e DNA em produtos terapêuticos, alimentares e de cuidados com a pele está a remodelar as indústrias com soluções personalizadas e de alta eficácia. À medida que a investigação avança, uma maior acessibilidade, um preço acessível e um apoio regulamentar irão acelerar a adoção, posicionando os ácidos nucleicos como os principais impulsionadores dos futuros mercados de saúde, nutrição e beleza.

Restrição/Desafio

“Baixa sensibilização pública e baixas taxas de adoção”

Apesar dos avanços nas terapias baseadas em RNA e DNA, nos aditivos alimentares funcionais e nos cuidados com a pele baseados em genes, muitos consumidores continuam desinformados ou céticos em relação a estas inovações.
Esta falta de sensibilização atrasa o crescimento do mercado e cria barreiras à aceitação, tornando difícil para as empresas conquistarem a confiança generalizada dos consumidores
Na terapêutica com ácidos nucleicos, a complexidade dos tratamentos baseados em RNA e DNA e as preocupações com a edição genética e a tecnologia de mRNA levaram à hesitação entre os doentes e os profissionais de saúde.
Conceitos errados sobre a segurança, os efeitos a longo prazo e as implicações éticas dos medicamentos à base de ácidos nucleicos dificultam ainda mais a adoção. As aprovações regulamentares e a validação clínica são essenciais, mas sem campanhas educativas eficazes, estas inovações têm dificuldade em obter uma ampla aceitação.
No mercado dos aditivos alimentares desportivos, os suplementos à base de ácido nucleico ainda não são comuns devido à falta de educação do consumidor sobre os seus benefícios. Muitas pessoas desconhecem como os ácidos nucleicos contribuem para a recuperação muscular, o metabolismo energético e o desempenho atlético geral.
Sem estratégias de marketing claras e comunicação científica, estes produtos mantêm-se como nichos de mercado, limitando a sua penetração no mercado.

Por exemplo,

Por exemplo, em junho de 2021, de acordo com a Elsevier BV, a importância da educação do consumidor em relação aos benefícios para a saúde e à segurança dos produtos probióticos. Destaca que uma maior consciencialização pode levar a uma melhor aceitação e a escolhas informadas entre os consumidores
Em julho de 2023, um artigo publicado A North America Overview of Dietary Supplements: Regulation, Market Trends, Usage during the COVID-19 Pandemic, and Health Effects, nos últimos 20 anos, o uso de suplementos alimentares (DS) cresceu na América do Norte, com a procura a aumentar durante a COVID-19 devido a receios sobre vacinas e alegações de reforço imunitário.
Apesar das evidências limitadas, as vendas aumentaram, levantando preocupações sobre a eficácia e segurança. A limitada sensibilização pública sublinha a necessidade de clareza regulamentar e de educação do consumidor sobre os benefícios e riscos do DS

A baixa sensibilização pública e as baixas taxas de adoção dificultam significativamente a expansão do mercado nestes setores. As empresas devem investir na educação do consumidor, na comunicação transparente e no marketing estratégico para construir confiança e acelerar a aceitação.
A colaboração com profissionais de saúde, influenciadores e entidades reguladoras pode ajudar a aumentar a consciencialização e melhorar a adoção pelo mercado

Âmbito de mercado das terapêuticas com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

O mercado é segmentado com base no tipo de produto, origem, utilizador final e canal de distribuição.

Segmentação	Sub-segmentação
Por produto	Terapêutica com Ácido Nucleico Terapêutica com Ácido Nucleico, por categoria Antisense Antisense, por moléculas Estou cansado. Aquecimento Golodirsen Inotersen Volanesorsen Outros Antisense, por drogas Espinosa Exondys 51 Tegsedi Outros Interferência de RNA Interferência de RNA, por moléculas Vutrisiran Givosiran Participando Lubrificar Interferência de RNA, por fármacos Abutres Givlaari Onpattro Oxlumo Interferência de RNA, por tipo Vírus de RNA de cadeia dupla (dsRNA) RNA de interferência pequeno (siRNA) microRNAs (miRNA) Oligonucleotídeos CPG Os oligonucleótidos CPG, por tipo Adjuvantes CpG em Vacinas Oligonucleotídeos CpG Tipo B Aptâmeros Outros Terapêutica com Ácido Nucleico, por Estrutura RNA de cadeia simples DNA de dupla fita DNA de cadeia simples RNA/DNA de cadeia simples Terapêutica com Ácido Nucleico, por Tipo de Medicamento Medicamentos comercializados/aprovados Medicamentos comercializados/aprovados, por tipo Medicamentos de ácido nucleico pequeno Vacinas de mRNA Outros Medicamentos Pipeline Terapêutica com Ácido Nucleico, por Aplicação Distúrbios genéticos Distúrbios neurológicos Doenças infecciosas Doenças autoimunes Outros Terapêutica com Ácido Nucleico, por Via de Administração Intratecal Subcutâneo Intravenoso Outros Produtos para o cuidado da pele com ácido nucleico Produtos para o cuidado da pele com ácido nucleico, por tipo Cuidados com a pele baseados em ADN Cuidados com a pele baseados em ADN, por tipo Soros de reparação de DNA Soros de reparação de DNA, por tipo Soros de ADN antienvelhecimento Soros de ADN hidratantes Séruns de reforço de colagénio à base de ADN Hidratantes com infusão de ADN Hidratantes com ADN, por tipo Cremes de dia Cremes de noite Cremes de Hidratação Profunda Outros Protetores solares baseados em ADN Protetores solares baseados em ADN, por tipo Proteção UV de largo espectro Protetores solares de ADN anti-fotoenvelhecimento Máscaras faciais baseadas em ADN Máscaras faciais baseadas em ADN, por tipo Máscaras de folha Máscaras de barro Máscaras de gel Outros Cremes para os olhos com infusão de ADN Cremes para os olhos com infusão de ADN, por tipo Cremes Anti-Olheiras Cremes para redução de linhas finas e rugas Cremes para redução do inchaço Outros Cuidados com a pele baseados em RNA Cuidados com a pele baseados em RNA, por tipo Cremes com infusão de RNA Tratamentos antienvelhecimento baseados em RNA Cremes com infusão de RNA, por tipo Cremes de RNA anti-envelhecimento Cremes de Reparação de Barreira Cremes de Hidratação Intensiva Outros Os tratamentos antienvelhecimento baseados em RNA, por tipo Formulações para redução de rugas Tratamentos de Rejuvenescimento da Pele Outros Produtos para o cuidado da pele com infusão de terapia genética Produtos para o cuidado da pele com infusão de terapia genética, por tipo Cuidados de pele personalizados com modificações de ADN/RNA Tratamentos epigenéticos para o cuidado da pele Outros Outros Produtos para o cuidado da pele com ácido nucleico, por tipo de pele Pele seca Pele normal Pele oleosa Pele mista Pele sensível Outros Produtos para o cuidado da pele com ácido nucleico, por embalagem Garrafas Garrafas, por tipo Garrafas de compressão Garrafas de bomba Frascos de spray Outros Tubos Tubos, por tipo Tampas giratórias Tampas Flip-Top Tubos de compressão sem ar Outros Frascos conta-gotas Frascos conta-gotas, por tipo Conta-gotas de pipeta Conta-gotas com botão de pressão Potes Potes, por tipo Tampas de Rosca Tampas Flip-Top Potes com espátula incluída Outros Ampolas Ampolas, por tipo Ampolas de uso único Ampolas Multidose Saquetas e bolsas Saquetas e bolsas, por tipo Sachês destacáveis Bolsas Resseláveis Outros Produtos para o cuidado da pele com ácido nucleico, por tamanho de embalagem Embalagem média (31 ML – 75 ML) Embalagem de pequena dimensão (1 ML – 30 ML) Embalagem de grande dimensão (76 ML – 200 ML) Embalagem extra grande (acima de 200 ml) Produtos para o cuidado da pele com ácido nucleico, por intervalo de preço Massa Prémio Luxo Produtos para o cuidado da pele com ácido nucleico, por aplicação Hidratação e Hidratação Hidratação e hidratação, por tipo Hidratação Profunda COM Ácidos Nucleicos Hidratação Profunda com Ácidos Nucleicos, Por Tipo Cremes Water-Lock à base de ADN Reforçadores de hidratação com RNA Séruns de hidratação de longa duração Séruns de hidratação de longa duração, por tipo Soros de RNA de hidratação 24 horas Tratamentos de retenção de humidade com ADN Fortalecimento da barreira cutânea Cremes de ceramida com infusão de ácido nucleico Potenciadores Epigenéticos de Resiliência da Pele Regeneração e reparação da pele Tratamentos Pós-Cirúrgicos e de Cura Intensiva Cremes para cicatrização de feridas à base de ADN Soros reparadores de cicatrizes com infusão de RNA Formulações para recuperação da barreira cutânea Tratamentos de Renovação Celular Soros de renovação da pele que estimulam o ADN Máscaras enzimáticas de reparação da pele baseadas em RNA Reparação de danos ao DNA Cremes para reversão de danos no ADN induzidos por UV Soros de Reparação Epigenética Outros Proteção UV e Reparação de Danos Solares Protetores solares baseados em ADN Proteção UVA/UVB de largo espectro Fórmulas de defesa contra o fotoenvelhecimento Tratamentos de reparação de ADN pós-solar Máscaras pós-exposição solar com infusão de ADN Géis de recuperação de queimaduras solares à base de RNA Proteção contra a luz azul e a poluição Cremes de Defesa Digital Alimentados a ADN Soros de proteção ambiental baseados em RNA Tratamento de acne e cicatrizes Soros de controlo de acne baseados em ADN Soros de ácido nucleico antibacteriano Tratamentos com RNA regulador de sebo Cremes para branqueamento de cicatrizes com RNA Corretores de marcas pós-acne Soros de Regeneração Tecidual Epigenética Tratamentos hormonais para o acne Cuidados com a pele para o equilíbrio hormonal baseado no ADN Géis anti-inflamatórios com infusão de RNA Controlo da oleosidade e redução de poros Cremes de equilíbrio de oleosidade com ADN Tónicos anti-poros à base de RNA Tratamento de hiperpigmentação e manchas escuras Corretores de manchas escuras Tratamentos de branqueamento de manchas baseados em ADN Redutores de descoloração alimentados por RNA Correção de tom de pele irregular Máscaras branqueadoras de pele baseadas em ADN Soluções para um tom de pele uniforme e direcionado para os genes Soros Inibidores da Melanina Inibidores da tirosinase baseados em DNA Soros branqueadores com RNA Tratamentos para a Hiperpigmentação Pós-Inflamatória (HIP) Corretores de marcas de acne com infusão de ácido nucleico Cremes redutores de vermelhidão à base de RNA Antienvelhecimento e redução de rugas Formulações que aumentam o colagénio Soros de colagénio com infusão de DNA Reforçadores de peptídeos baseados em RNA Máscaras de colagénio com estimulação genética Outros Firmeza da pele e melhoria da elasticidade Soros para firmamento da pele à base de ADN Cremes que aumentam a elasticidade com RNA Máscaras de lifting facial com infusão de ácido nucleico Outros Tratamento de linhas finas Corretores de linha da testa Cremes Redutores de Pés de Galinha Sérums antirrugas para a zona dos olhos Tratamento do Sulco Nasolabial Outros Reparação de rugas profundas Alternativas ao retinol baseadas no ADN Soros epigenéticos redutores de rugas Outros Cuidados com a pele sensível e redução da inflamação Fórmulas calmantes e antivermelhidão Tratamentos para a rosácea baseados em RNA Máscaras calmantes com infusão de ADN Cuidados com a pele hipoalergénicos à base de ADN Cremes de RNA para pele sensível Soros de ADN sem fragrância Tratamentos anti-inflamatórios com ácido nucleico Soros redutores de citocinas com ADN Géis redutores de irritação baseados em RNA Aditivos alimentares desportivos de ácido nucleico Os aditivos alimentares desportivos de ácido nucleico, por aplicação Suplementos desportivos Pó Cápsulas Outros Comida Desportiva
Por fonte	Ácidos Nucleicos Naturais À base de plantas Derivado do Mar Outros Ácidos Nucleicos Sintéticos
Por utilizador final	Consumidores Individuais/Atendimento Domiciliário Mulher Homens Unissex Uso profissional/de instalações Clínicas de Dermatologia Salões de beleza e spas Clínicas especializadas Hospital Outros
Por canal de distribuição	Licitação Direta Vendas no retalho Baseado em loja Supermercados/Hipermercados Lojas especializadas em beleza Farmácias e Drogarias Clínicas de Dermatologia e Termas Médicas Varejo de viagem Outros Não baseado em loja Sites de comércio eletrónico/farmácias Sites propriedade da empresa Outros

Análise regional do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

“Os EUA são o país dominante no mercado das terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele”

Os EUA lideram o mercado, impulsionados por um setor de biotecnologia bem estabelecido, elevados gastos dos consumidores em produtos de bem-estar e uma forte presença de empresas farmacêuticas, nutracêuticas e de cuidados com a pele líderes
Os EUA detêm uma quota de mercado significativa devido à rápida adopção de terapias baseadas em ácido nucleico, à crescente procura de aditivos alimentares funcionais e que melhoram o desempenho e ao interesse crescente em soluções de cuidados da pele com base científica.
Os investimentos robustos em I&D, especialmente em terapia genética e tecnologia de mRNA, juntamente com quadros regulamentares de apoio e acesso a capacidades de fabrico avançadas, contribuem para um domínio sustentado do mercado.
Além disso, a crescente consciencialização sobre a saúde personalizada, a crescente preferência por produtos de rótulo limpo e bioativos e a disponibilidade de marcas de cuidados com a pele premium estão a alimentar a expansão do mercado em toda a região.

“Os EUA devem registar a maior taxa de crescimento”

Espera-se que a região dos EUA testemunhe o crescimento mais rápido, impulsionado pelo aumento dos gastos em saúde, pela crescente procura de bem-estar personalizado e pelo rápido crescimento das indústrias de biotecnologia e cosmética.
Países como os EUA estão a tornar-se um importante motor de crescimento devido às suas grandes populações, às crescentes preocupações com a saúde relacionadas com o estilo de vida e ao crescente foco nos cuidados preventivos e no bem-estar estético.
Os EUA, com o seu setor biofarmacêutico avançado e a indústria de cuidados com a pele orientada para a inovação, continuam a liderar na adoção de tecnologias baseadas em ácido nucleico e produtos de beleza baseados na ciência.
A expansão das plataformas de comércio eletrónico, o crescente acesso dos consumidores a produtos premium e a localização de marcas internacionais aceleram ainda mais o crescimento do mercado na região

Participação no mercado de produtos terapêuticos com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença na América do Norte, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa, lançamento do produto, amplitude e abrangência do produto, domínio da aplicação. Os pontos de dados fornecidos acima estão apenas relacionados com o foco das empresas em relação ao mercado.

Os principais líderes de mercado que operam no mercado são:

Pfizer Inc. (EUA)
Biogen (EUA)
Alnylam Pharmaceuticals, Inc. (EUA)
Ionis Pharmaceuticals (EUA)
Novartis AG (Suíça)
Spark Therapeutics, Inc. (EUA)
Tecnologia Biofarmacêutica Zhejiang Haichang Co., Ltd. (China)
Modern, Inc. (LOUSE)
AstraZeneca (Reino Unido/Suécia)
Sarepta Therapeutics, Inc. (EUA)
Remy Laure (França)
NOVO (EUA)
MoonGlow (EUA)
The Naked Chemist (Nova Zelândia)
SKINSHIFT (EUA)
Remy Laure (França)
NOVO (EUA)
MoonGlow (Ucrânia)
The Naked Chemist (Nova Zelândia)
SKINSHIFT (EUA)
Bio Jouvance Paris Consumidor (EUA)
Instituto DNA Skin (EUA)
Juliette Armand (Grécia)
Kalichem srl (Itália)
NIPPON PAPER INDUSTRIES CO., LTD. (Japão)
PostQuam (Espanha)
Shopatdna.com (Índia)

Últimos desenvolvimentos no mercado da terapêutica com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Em fevereiro de 2025, a Biogen e a Stoke Therapeutics estabeleceram uma parceria para desenvolver e comercializar o zorevunersen, uma potencial terapia modificadora da doença, a primeira da classe, para a síndrome de Dravet. Este oligonucleótido anti-sentido experimental tem como alvo o gene SCN1A para reduzir as convulsões e melhorar a cognição. Um estudo de Fase 3 começa em 2025, com registos regulamentares previstos para 2027. A Stoke mantém os direitos nos EUA, enquanto a Biogen trata da comercialização na América do Norte.
Em março de 2025, a Biogen irá estabelecer a sua nova sede na América do Norte, em Kendall Common, em Cambridge, Massachusetts, como parte de uma consolidação imobiliária de vários anos. A instalação de última geração, com inauguração prevista para 2028, irá promover a colaboração, a inovação e a sustentabilidade, ao mesmo tempo que irá acolher as equipas de investigação, desenvolvimento e comercial da Biogen, juntamente com o Biogen CoLab para a educação em ciências biológicas.
Em março de 2025, a Ionis Pharmaceuticals, Inc. anunciou que o Wainzua (Eplontersen) foi aprovado pela Agência Europeia do Medicamento (EMA) para o tratamento da amiloidose transtirretina hereditária (hATTR). Esta terapia anti-sentido tem como alvo a causa subjacente da doença, oferecendo uma nova opção terapêutica para os doentes que sofrem desta condição rara e com risco de vida.
Em fevereiro de 2024, a Pfizer Inc. e o UT Southwestern Medical Center estabeleceram uma parceria para desenvolver tecnologias avançadas de administração de RNA para medicina genética. Esta colaboração integra a experiência da UTSW em sistemas de entrega de nanopartículas lipídicas (LNP) com a inovação de RNA da Pfizer para melhorar as terapias baseadas em RNA. A investigação visa expandir as aplicações de edição genética, melhorar a entrega direcionada e acelerar o desenvolvimento de medicamentos genéticos de próxima geração
Em janeiro de 2022, a Pfizer Inc. estabeleceu uma parceria com a Acuitas Therapeutics para expandir a tecnologia de distribuição de nanopartículas lipídicas (LNP) para vacinas e produtos terapêuticos baseados em mRNA. Este acordo permite à Pfizer licenciar a tecnologia LNP da Acuitas para até 10 alvos, reforçando a sua estratégia de mRNA. A colaboração melhora o desenvolvimento de vacinas e permite medicamentos genéticos de última geração, com base no sucesso da COMIRNATY, a vacina Pfizer-BioNTech COVID-19.

SKU-73896

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Click on image to enlarge

Painel interativo de análise de dados
Painel de análise da empresa para oportunidades de elevado potencial de crescimento
Acesso de analista de pesquisa para personalização e customização. consultas
Análise da concorrência com painel interativo
Últimas notícias, atualizações e atualizações Análise de tendências
Aproveite o poder da análise de benchmark para um rastreio abrangente da concorrência

Pedido de demonstração

Índice

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 DBMR VENDOR SHARE ANALYSIS

2.1 MARKET END USER COVERAGE GRID

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 PESTAL ANALYSIS

4.2 PORTER’S FIVE FORCES

4.2.1 THREAT OF NEW ENTRANTS

4.2.2 BARGAINING POWER OF BUYERS

4.2.3 BARGAINING POWER OF SUPPLIERS

4.2.4 THREAT OF SUBSTITUTES

4.2.5 COMPETITIVE RIVALRY

4.3 IMPORT EXPORT SCENARIO

4.4 PRICING ANALYSIS

4.5 PRODUCTION CAPACITY FOR TOP MANUFACTURERS

4.6 BRAND OUTLOOK

4.6.1 BRAND COMPARATIVE ANALYSIS OF NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET

4.6.2 PRODUCT VS BRAND OVERVIEW

4.6.2.1 PRODUCT OVERVIEW

4.6.2.2 BRAND OVERVIEW

4.7 CONSUMER BUYING BEHAVIOUR FOR THE NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.7.1 AWARENESS AND EDUCATION

4.7.2 HEALTH AND PERFORMANCE-ORIENTED BUYERS

4.7.3 PREFERENCE FOR NATURAL AND SCIENTIFIC FORMULATIONS

4.7.4 PRICE SENSITIVITY AND WILLINGNESS TO PAY FOR QUALITY

4.7.5 ROLE OF BRAND TRUST AND REVIEWS

4.7.6 DIGITAL-FIRST SHOPPING EXPERIENCE

4.7.7 REGULATORY AND SAFETY CONCERNS

4.7.8 SUSTAINABILITY AND ETHICAL CONSIDERATIONS

4.8 FACTORS AFFECTING BUYING DECISION FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.8.1 SCIENTIFIC VALIDATION AND EFFICACY

4.8.2 PRICE AND PERCEIVED VALUE

4.8.3 BRAND REPUTATION AND TRUST

4.8.4 PERSONAL HEALTH AND SKIN CONCERNS

4.8.5 DIGITAL INFLUENCE AND E-COMMERCE ACCESSIBILITY

4.8.6 REGULATORY APPROVALS AND SAFETY ASSURANCE

4.8.7 ETHICAL AND SUSTAINABILITY CONSIDERATIONS

4.8.8 AVAILABILITY AND CONVENIENCE

4.9 IMPACT OF ECONOMIC SLOWDOWN ON NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.9.1 IMPACT ON PRICE

4.9.2 IMPACT ON SUPPLY CHAIN

4.9.3 IMPACT ON SHIPMENT

4.9.4 IMPACT ON DEMAND

4.9.5 IMPACT ON STRATEGIC DECISIONS

4.1 PRODUCT ADOPTION SCENARIO FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKET

4.10.1 AWARENESS AND MARKET PENETRATION

4.10.2 CONSUMER SEGMENTATION AND ADOPTION TRENDS

4.10.3 INFLUENCE OF SCIENTIFIC RESEARCH AND REGULATORY APPROVALS

4.10.4 PRICING, ACCESSIBILITY, AND DISTRIBUTION CHANNELS

4.11 RAW MATERIAL SOURCING ANALYSIS

4.11.1 SOURCES OF NUCLEIC ACIDS FOR FOOD ADDITIVES AND SKINCARE

4.11.2 SUPPLY CHAIN CHALLENGES IN RAW MATERIAL PROCUREMENT

4.11.3 QUALITY CONTROL AND REGULATORY COMPLIANCE

4.11.4 COST IMPLICATIONS OF RAW MATERIAL SOURCING

4.11.5 SUSTAINABILITY AND ETHICAL SOURCING

4.12 SUPPLY CHAIN ANALYSIS FOR NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES MARKET AND NORTH AMERICA NUCLEIC ACID SKIN CARE MARKETS

4.13 OVERVIEW

4.13.1 LOGISTIC COST SCENARIO

4.13.2 IMPORTANCE OF LOGISTICS SERVICE PROVIDERS

4.14 PATENT ANALYSIS

4.15 PIPELINE

4.16 MERGERS & ACQUISITIONS

4.17 INDUSTRY INSIGHTS

5 PIPELINE ANALYSIS:

6 EPIDEMIOLOGY

6.1 INCIDENCE BY GENDER

6.2 TREATMENT RATES

6.3 MORTALITY RATES

6.4 DRUG ADHERENCE AND THERAPY SWITCH MODELS

6.5 PATIENT TREATMENT SUCCESS RATES

7 REGULATORY COVERAGE

8 MARKET OVERVIEW

8.1 DRIVERS

8.1.1 GROWING DEMAND FOR FUNCTIONAL FOODS, NUTRACEUTICALS, AND BIOACTIVE SKINCARE INGREDIENTS

8.1.2 RISING INFLUENCE OF PERSONALIZED MEDICINE AND CUSTOMIZED SKINCARE SOLUTIONS

8.1.3 FAVORABLE REGULATORY POLICIES AND RISING R&D INVESTMENTS IN GENE-BASED THERAPIES

8.1.4 INCREASING PREVALENCE OF CHRONIC DISEASES AND AN AGING NORTH AMERICA POPULATION

8.2 RESTRAINTS

8.2.1 INCREASING TREATMENT COSTS DUE TO HIGH PRODUCTION EXPENSES IN GENE-BASED THERAPIES

8.2.2 POTENTIAL RISKS AND SIDE EFFECTS OF GENE-BASED TREATMENTS

8.3 OPPORTUNITIES

8.3.1 BREAKTHROUGHS IN RNA AND DNA-BASED THERAPIES, FOOD ADDITIVES, AND SKINCARE INNOVATIONS

8.3.2 EXPANSION THROUGH STRATEGIC PARTNERSHIPS AND COLLABORATIONS

8.3.3 TECHNOLOGICAL ADVANCEMENTS IN DRUG DELIVERY SYSTEMS

8.4 CHALLENGES

8.4.1 LOW PUBLIC AWARENESS AND SLOW ADOPTION RATES

8.4.2 INTELLECTUAL PROPERTY COMPLEXITIES AND PATENT-RELATED HURDLES

9 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT

9.1 OVERVIEW

9.2 NUCLEIC ACID THERAPEUTICS

9.2.1 BY CATEGORY

9.2.1.1 ANTISENSE

9.2.1.1.1 BY MOLECULES

9.2.1.1.1.1 NUSINERSEN

9.2.1.1.1.2 ETEPLIRSEN

9.2.1.1.1.3 GOLODIRSEN

9.2.1.1.1.4 INOTERSEN

9.2.1.1.1.5 VOLANESORSEN

9.2.1.1.1.6 OTHERS

9.2.1.1.2 BY DRUGS

9.2.1.1.2.1 SPINRAZA

9.2.1.1.2.2 EXONDYS 51

9.2.1.1.2.3 TEGSEDI

9.2.1.1.2.4 OTHERS

9.2.2 RNA INTERFERENCE

9.2.2.1 BY MOLECULES

9.2.2.1.1 VUTRISIRAN

9.2.2.1.2 GIVOSIRAN

9.2.2.1.3 PATISIRAN

9.2.2.1.4 LUMASIRAN

9.2.2.2 BY DRUGS

9.2.2.2.1 AMVUTRA

9.2.2.2.2 GIVLAARI

9.2.2.2.3 ONPATTRO

9.2.2.2.4 OXLUMO

9.2.2.3 BY TYPE

9.2.2.3.1 DOUBLE-STRANDED RNA VIRUSES (DSRNA)

9.2.2.3.2 SMALL INTERFERING RNA (SIRNA)

9.2.2.3.3 MICRORNAS (MIRNA)

9.2.3 CPG OLIGONUCLEOTIDES

9.2.3.1 BY TYPE

9.2.3.1.1 CPG ADJUVANTS IN VACCINES

9.2.3.1.2 TYPE B CPG OLIGONUCLEOTIDES

9.2.4 APTAMERS

9.2.5 OTHERS

9.2.6 BY STRUCTURE

9.2.6.1 SINGLE-STRANDED RNA

9.2.6.2 DOUBLE-STRANDED DNA

9.2.6.3 SINGLE-STRANDED DNA

9.2.6.4 SINGLE-STRANDED RNA/DNA

9.2.7 BY DRUG TYPE

9.2.7.1 MARKETED/ APPROVED DRUGS

9.2.7.1.1 SMALL NUCLEIC ACID DRUGS

9.2.7.1.2 MRNA VACCINES

9.2.7.1.3 OTHERS

9.2.7.2 PIPELINE DRUGS

9.2.8 BY APPLICATION

9.2.8.1 GENETIC DISORDERS

9.2.8.2 NEUROLOGICAL DISORDERS

9.2.8.3 INFECTIOUS DISEASES

9.2.8.4 AUTOIMMUNE DISEASES

9.2.8.5 OTHERS

9.2.9 BY ROUTE OF ADMINISTRATION

9.2.9.1 INTRATHECAL

9.2.9.2 SUBCUTANEOUS

9.2.9.3 INTRAVENOUS

9.2.9.4 OTHERS

9.3 NUCLEIC ACID SKIN CARE PRODUCTS

9.3.1 DNA-BASED SKIN CARE

9.3.1.1 DNA REPAIR SERUMS

9.3.1.1.1 ANTI-AGING DNA SERUMS

9.3.1.1.2 HYDRATING DNA SERUMS

9.3.1.1.3 DNA-BASED COLLAGEN-BOOSTING SERUMS

9.3.2 DNA-INFUSED MOISTURIZERS

9.3.2.1.1 DAY CREAMS

9.3.2.1.2 NIGHT CREAMS

9.3.2.1.3 DEEP HYDRATION CREAMS

9.3.2.1.4 OTHERS

9.3.2.2 DNA-BASED SUNSCREENS

9.3.2.2.1 BROAD-SPECTRUM UV PROTECTION

9.3.2.2.2 ANTI-PHOTOAGING DNA SUNSCREENS

9.3.2.3 DNA-BASED FACE MASKS

9.3.2.3.1 SHEET MASKS

9.3.2.3.2 CLAY MASKS

9.3.2.3.3 GEL MASKS

9.3.2.3.4 OTHERS

9.3.2.4 DNA-INFUSED EYE CREAMS

9.3.2.4.1 ANTI-DARK CIRCLE CREAMS

9.3.2.4.2 FINE LINE & WRINKLE REDUCTION CREAMS

9.3.2.4.3 PUFFINESS REDUCTION CREAMS

9.3.2.4.4 OTHERS

9.4 RNA-BASED SKIN CARE

9.4.1 RNA-INFUSED CREAMS

9.4.1.1 ANTI-AGING RNA CREAMS

9.4.1.2 BARRIER REPAIR CREAMS

9.4.1.3 INTENSIVE MOISTURE CREAMS

9.4.1.4 OTHERS

9.4.2 RNA-BASED ANTI-AGING TREATMENTS

9.4.2.1 WRINKLE REDUCTION FORMULATIONS

9.4.2.2 SKIN REJUVENATION TREATMENTS

9.4.2.3 OTHERS

9.4.3 GENE THERAPY-INFUSED SKIN CARE PRODUCTS

9.4.3.1 PERSONALIZED SKINCARE WITH DNA/RNA MODIFICATIONS

9.4.3.2 EPIGENETIC SKIN CARE TREATMENTS

9.4.3.3 OTHERS

9.4.4 BY SKIN TYPE

9.4.4.1 DRY SKIN

9.4.4.2 NORMAL SKIN

9.4.4.3 OILY SKIN

9.4.4.4 COMBINATION SKIN

9.4.4.5 SENSITIVE SKIN

9.4.4.6 OTHERS

9.4.5 BY PACKAGING

9.4.5.1 BOTTLES

9.4.5.1.1 SQUEEZE BOTTLES

9.4.5.1.2 PUMP BOTTLES

9.4.5.1.3 SPRAY BOTTLES

9.4.5.1.4 OTHERS

9.4.5.2 TUBES

9.4.5.2.1 TWIST CAPS

9.4.5.2.2 FLIP-TOP CAPS

9.4.5.2.3 AIRLESS SQUEEZE TUBES

9.4.5.2.4 OTHERS

9.4.5.3 DROPPER BOTTLES

9.4.5.3.1 PIPETTE DROPPERS

9.4.5.3.2 PUSH-BUTTON DROPPERS

9.4.5.4 JARS

9.4.5.4.1 SCREW-TOP LIDS

9.4.5.4.2 FLIP-TOP LIDS

9.4.5.4.3 SPATULA-INCLUDED JARS

9.4.5.4.4 OTHERS

9.4.5.5 AMPOULES

9.4.5.5.1 SINGLE-USE AMPOULES

9.4.5.5.2 MULTI-DOSE AMPOULES

9.4.5.6 SACHETS AND POUCHES

9.4.5.6.1 TEAR-OFF SACHETS

9.4.5.6.2 RESEALABLE POUCHES

9.4.5.7 OTHERS

9.4.6 BY PACKAGING SIZE

9.4.6.1 MEDIUM-SIZED PACKAGING (31 ML – 75 ML)

9.4.6.2 SMALL-SIZED PACKAGING (1 ML – 30 ML)

9.4.6.3 LARGE-SIZED PACKAGING (76 ML – 200 ML)

9.4.6.4 EXTRA-LARGE PACKAGING (ABOVE 200 ML)

9.4.7 BY PRICE RANGE

9.4.7.1 MASS

9.4.7.2 PREMIUM

9.4.7.3 LUXURY

9.4.8 BY APPLICATION

9.4.8.1 MOISTURIZATION & HYDRATION

9.4.8.1.1 DEEP HYDRATION WITH NUCLEIC ACIDS

9.4.8.1.1.1 DNA-BASED WATER-LOCK CREAMS

9.4.8.1.1.2 RNA-POWERED HYDRATION BOOSTERS

9.4.8.1.2 LONG-LASTING HYDRATION SERUMS

9.4.8.1.2.1 24-HOUR HYDRATION RNA SERUMS

9.4.8.1.2.2 DNA-POWERED MOISTURE-LOCKING TREATMENTS

9.4.8.1.3 SKIN BARRIER STRENGTHENING

9.4.8.1.3.1 NUCLEIC ACID-INFUSED CERAMIDE CREAMS

9.4.8.1.3.2 EPIGENETIC SKIN RESILIENCE ENHANCERS

9.4.8.2 SKIN REGENERATION & REPAIR

9.4.8.2.1 POST-SURGERY & INTENSIVE HEALING TREATMENTS

9.4.8.2.2 DNA-BASED WOUND HEALING CREAMS

9.4.8.2.3 RNA-INFUSED SCAR-REPAIR SERUMS

9.4.8.2.4 SKIN BARRIER RECOVERY FORMULATIONS

9.4.8.2.5 CELLULAR RENEWAL TREATMENTS

9.4.8.2.5.1 DNA-STIMULATING SKIN RENEWAL SERUMS

9.4.8.2.5.2 RNA-BASED ENZYMATIC SKIN REPAIR MASKS

9.4.8.2.6 DNA DAMAGE REPAIR

9.4.8.2.6.1 UV-INDUCED DNA DAMAGE REVERSAL CREAMS

9.4.8.2.6.2 EPIGENETIC REPAIR SERUMS

9.4.8.2.6.3 OTHERS

9.4.8.3 UV PROTECTION & SUN DAMAGE REPAIR

9.4.8.3.1 DNA-BASED SUNSCREENS

9.4.8.3.1.1 BROAD-SPECTRUM UVA/UVB PROTECTION

9.4.8.3.1.2 PHOTOAGING DEFENSE FORMULAS

9.4.8.3.2 AFTER-SUN DNA REPAIR TREATMENTS

9.4.8.3.2.1 DNA-INFUSED POST-SUN EXPOSURE MASKS

9.4.8.3.2.2 RNA-BASED SUNBURN RECOVERY GELS

9.4.8.3.3 BLUE LIGHT & POLLUTION PROTECTION

9.4.8.3.3.1 DNA-POWERED DIGITAL DEFENSE CREAMS

9.4.8.3.3.2 RNA-BASED ENVIRONMENTAL SHIELD SERUMS

9.4.8.4 ACNE & SCAR TREATMENT

9.4.8.4.1 DNA-BASED ACNE CONTROL SERUMS

9.4.8.4.1.1 ANTI-BACTERIAL NUCLEIC ACID SERUMS

9.4.8.4.1.2 SEBUM-REGULATING RNA TREATMENTS

9.4.8.4.2 RNA-POWERED SCAR FADING CREAMS

9.4.8.4.2.1 POST-ACNE MARK CORRECTORS

9.4.8.4.2.2 EPIGENETIC TISSUE REGENERATION SERUMS

9.4.8.4.3 HORMONAL ACNE TREATMENTS

9.4.8.4.3.1 DNA-BASED HORMONAL BALANCING SKINCARE

9.4.8.4.3.2 RNA-INFUSED ANTI-INFLAMMATORY GELS

9.4.8.4.4 OIL-CONTROL & PORE REDUCTION

9.4.8.4.4.1 DNA-POWERED OIL-BALANCING CREAMS

9.4.8.4.4.2 RNA-BASED PORE-TIGHTENING TONERS

9.4.8.5 HYPERPIGMENTATION & DARK SPOT TREATMENT

9.4.8.5.1 DARK SPOT CORRECTORS

9.4.8.5.1.1 DNA-BASED SPOT FADING TREATMENTS

9.4.8.5.1.2 RNA-POWERED DISCOLORATION REDUCERS

9.4.8.5.2 UNEVEN SKIN TONE CORRECTION

9.4.8.5.2.1 DNA-BASED SKIN BRIGHTENING MASKS

9.4.8.5.2.2 GENE-TARGETED EVEN SKIN TONE SOLUTIONS

9.4.8.5.3 MELANIN-INHIBITING SERUMS

9.4.8.5.3.1 DNA-BASED TYROSINASE INHIBITORS

9.4.8.5.3.2 RNA-POWERED BRIGHTENING SERUMS

9.4.8.5.4 POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS

9.4.8.5.4.1 NUCLEIC ACID-INFUSED ACNE MARK CORRECTORS

9.4.8.5.4.2 RNA-BASED REDNESS-REDUCING CREAMS

9.4.8.6 ANTI-AGING & WRINKLE REDUCTION

9.4.8.6.1 COLLAGEN-BOOSTING FORMULATIONS

9.4.8.6.1.1 DNA-INFUSED COLLAGEN SERUMS

9.4.8.6.1.2 RNA-BASED PEPTIDE BOOSTERS

9.4.8.6.1.3 GENE-STIMULATING COLLAGEN MASKS

9.4.8.6.1.4 OTHERS

9.4.8.6.2 SKIN FIRMING & ELASTICITY IMPROVEMENT

9.4.8.6.2.1 DNA-BASED SKIN TIGHTENING SERUMS

9.4.8.6.2.2 RNA-POWERED ELASTICITY-ENHANCING CREAMS

9.4.8.6.2.3 NUCLEIC ACID-INFUSED FACIAL LIFTING MASKS

9.4.8.6.2.4 OTHERS

9.4.8.6.3 FINE LINE TREATMENT

9.4.8.6.3.1 FOREHEAD LINE CORRECTORS

9.4.8.6.3.2 CROW’S FEET REDUCTION CREAMS

9.4.8.6.3.3 UNDER-EYE WRINKLE SERUMS

9.4.8.6.3.4 NASOLABIAL FOLD TREATMENT

9.4.8.6.3.5 OTHERS

9.4.8.6.4 DEEP WRINKLE REPAIR

9.4.8.6.4.1 DNA-BASED RETINOL ALTERNATIVES

9.4.8.6.4.2 EPIGENETIC WRINKLE-REDUCING SERUMS

9.4.8.6.4.3 OTHERS

9.4.8.7 SENSITIVE SKIN CARE & INFLAMMATION REDUCTION

9.4.8.7.1 SOOTHING & ANTI-REDNESS FORMULATIONS

9.4.8.7.1.1 RNA-BASED ROSACEA TREATMENTS

9.4.8.7.1.2 DNA-INFUSED CALMING MASKS

9.4.8.7.2 HYPOALLERGENIC DNA-BASED SKINCARE

9.4.8.7.2.1 SENSITIVE SKIN RNA CREAMS

9.4.8.7.2.2 FRAGRANCE-FREE DNA SERUMS

9.4.8.7.3 ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS

9.4.8.7.3.1 DNA-POWERED CYTOKINE-REDUCING SERUMS

9.4.8.7.3.2 RNA-BASED IRRITATION-REDUCING GELS

9.5 NUCLEIC ACID SPORTS FOOD ADDITIVES

9.5.1 SPORTS SUPPLEMENTS

9.5.1.1 POWDER

9.5.1.2 CAPSULES

9.5.1.3 OTHERS

9.5.2 SPORTS FOOD

10 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE

10.1 OVERVIEW

10.2 NATURAL NUCLEIC ACIDS

10.2.1 PLANT-BASED

10.2.2 MARINE-DERIVED

10.2.3 OTHERS

10.3 SYNTHETIC NUCLEIC ACIDS

11 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER

11.1 OVERVIEW

11.2 INDIVIDUAL CONSUMERS/ HOME HEALTHCARE

11.2.1 WOMEN

11.2.2 MEN

11.2.3 UNISEX

11.3 PROFESSIONAL/FACILITY USE

11.3.1 DERMATOLOGY CLINICS

11.3.2 BEAUTY SALONS & SPAS

11.3.3 SPECIALTY CLINICS

11.3.4 HOSPITAL

11.3.5 OTHERS

12 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL

12.1 OVERVIEW

12.2 DIRECT TENDER

12.3 RETAIL SALES

12.3.1 BY TYPE

12.3.1.1 STORE BASED

12.3.1.1.1 SUPERMARKETS/HYPERMARKETS

12.3.1.1.2 SPECIALTY BEAUTY STORES

12.3.1.1.3 PHARMACIES & DRUGSTORES

12.3.1.1.4 DERMATOLOGY CLINICS & MEDICAL SPAS

12.3.1.1.5 TRAVEL RETAIL

12.3.1.1.6 OTHERS

12.3.1.2 NON STORE BASED

12.3.1.2.1 E-COMMERCE/PHARMACY WEBSITES

12.3.1.2.2 COMPANY-OWNED WEBSITES

12.4 OTHERS

13 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION

13.1 NORTH AMERICA

13.1.1 U.S.

13.1.2 CANADA

13.1.3 MEXICO

14 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET, COMPANY LANDSCAPE

14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

15 COMPANY PROFILES

15.1 PFIZER INC.

15.1.1 COMPANY SNAPSHOT

15.1.2 REVENUE ANALYSIS

15.1.3 COMPANY SHARE ANALYSIS

15.1.4 PRODUCT PORTFOLIO

15.1.5 RECENT DEVELOPMENTS

15.2 BIOGEN

15.2.1 COMPANY SNAPSHOT

15.2.2 RECENT FINANCIALS

15.2.3 COMPANY SHARE ANALYSIS

15.2.4 PRODUCT PORTFOLIO

15.2.5 RECENT DEVELOPMENTS/NEWS

15.3 ALNYLAM PHARMACEUTICALS, INC.

15.3.1 COMPANY SNAPSHOT

15.3.2 RECENT FINANCIALS

15.3.3 COMPANY SHARE ANALYSIS

15.3.4 PRODUCT PORTFOLIO

15.3.5 RECENT NEWS

15.4 SAREPTA THERAPEUTICS, INC.

15.4.1 COMPANY SNAPSHOT

15.4.2 REVENUE ANALYSIS

15.4.3 COMPANY SHARE ANALYSIS

15.4.4 PRODUCT PORTFOLIO

15.4.5 RECENT DEVELOPMENT

15.5 IONIS PHARMACEUTICALS, INC.

15.5.1 COMPANY SNAPSHOT

15.5.2 REVENUE ANALYSIS

15.5.3 COMPANY SHARE ANALYSIS

15.5.4 PIPELINE PRODUCT PORTFOLIO

15.5.5 RECENT DEVELOPMENTS

15.6 ASTRAZENECA

15.6.1 COMPANY SNAPSHOT

15.6.2 RECENT FINANCIALS

15.6.3 PIPELINE PRODUCT PORTFOLIO

15.6.4 RECENT DEVELOPMENT

15.7 MODERNA, INC.

15.7.1 COMPANY SNAPSHOT

15.7.2 RECENT FINANCIALS

15.7.3 PIPELINE PRODUCT PORTFOLIO

15.7.4 RECENT DEVELOPMENT

15.8 NOVARTIS AG

15.8.1 COMPANY SNAPSHOT

15.8.2 REVENUE ANALYSIS

15.8.3 PRODUCT PORTFOLIO

15.8.4 RECENT DEVELOPMENTS

15.9 SPARK THERAPEUTICS, INC.

15.9.1 COMPANY SNAPSHOT

15.9.2 PIPELINE PRODUCT PORTFOLIO

15.9.3 RECENT DEVELOPMENT

15.1 ZHEJIANG HAICHANG BIOPHARMACEUTICAL TECHNOLOGY CO., LTD.

15.10.1 COMPANY SNAPSHOT

15.10.2 PIPELINE PRODUCT PORTFOLIO

15.10.3 RECENT DEVELOPMENT

16 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY LANDSCAPE

16.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

17 COMPANY PROFILES

17.1 REMY LAURE

17.1.1 COMPANY SNAPSHOT

17.1.2 COMPANY SHARE ANALYSIS

17.1.3 PRODUCT PORTFOLIO

17.1.4 RECENT DEVELOPMENT

17.2 NEOVA

17.2.1 COMPANY SNAPSHOT

17.2.2 COMPANY SHARE ANALYSIS

17.2.3 PRODUCT PORTFOLIO

17.2.4 RECENT DEVELOPMENT

17.3 MOONGLOW

17.3.1 COMPANY SNAPSHOT

17.3.2 COMPANY SHARE ANALYSIS

17.3.3 PRODUCT PORTFOLIO

17.3.4 RECENT DEVELOPMENT

17.4 THE NAKED CHEMIST

17.4.1 COMPANY SNAPSHOT

17.4.2 COMPANY SHARE ANALYSIS

17.4.3 PRODUCT PORTFOLIO

17.4.4 RECENT DEVELOPMENT

17.5 SKINSHIFT

17.5.1 COMPANY SNAPSHOT

17.5.2 COMPANY SHARE ANALYSIS

17.5.3 PRODUCT PORTFOLIO

17.5.4 RECENT DEVELOPMENT

17.6 BIO JOUVANCE PARIS CONSUMER

17.6.1 COMPANY SNAPSHOT

17.6.2 PRODUCT PORTFOLIO

17.6.3 RECENT DEVELOPMENT

17.7 DNA SKIN INSTITUTE

17.7.1 COMPANY SNAPSHOT

17.7.2 PRODUCT PORTFOLIO

17.7.3 RECENT DEVELOPMENT

17.8 JULIETTE ARMAND

17.8.1 COMPANY SNAPSHOT

17.8.2 PRODUCT PORTFOLIO

17.8.3 RECENT DEVELOPMENT

17.9 KALICHEM S.R.L.

17.9.1 COMPANY SNAPSHOT

17.9.2 PRODUCT PORTFOLIO

17.9.3 RECENT DEVELOPMENT

17.1 NIPPON PAPER INDUSTRIES CO., LTD.

17.10.1 COMPANY SNAPSHOT

17.10.2 REVENUE ANALYSIS

17.10.3 PRODUCT PORTFOLIO

17.10.4 RECENT DEVELOPMENT

17.11 POSTQUAM

17.11.1 COMPANY SNAPSHOT

17.11.2 PRODUCT PORTFOLIO

17.11.3 RECENT DEVELOPMENT

17.12 SHOPATDNA.COM

17.12.1 COMPANY SNAPSHOT

17.12.2 PRODUCT PORTFOLIO

17.12.3 RECENT DEVELOPMENT

18 QUESTIONNAIRE

19 RELATED REPORTS

Lista de Tabela

TABLE 1 PRODUCTION CAPACITY FOR TOP MANUFACTURERS

TABLE 2 NORTH AMERICA CLINICAL TRIAL MARKET FOR NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 3 DISTRIBUTION OF PRODUCTS AND PROJECTS BY PHASE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 4 DISTRIBUTION OF PROJECTS BY THERAPEUTIC AREA AND PHASE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

TABLE 5 OVERVIEW OF THE EPIDEMIOLOGICAL DATA FOR ALZHEIMER'S DISEASE (AD), PARKINSON'S DISEASE (PD), AMYOTROPHIC LATERAL SCLEROSIS (ALS), RHEUMATOID ARTHRITIS (RA), AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE),

TABLE 6 REGULATORY COVERAGE

TABLE 7 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT, 2024-2032 (USD THOUSANDS)

TABLE 8 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 9 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 10 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 11 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 12 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 13 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 14 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 15 NORTH AMERICA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 16 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 17 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 18 NORTH AMERICA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 19 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 20 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 21 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 22 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 23 NORTH AMERICA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 24 NORTH AMERICA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 25 NORTH AMERICA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 26 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 27 NORTH AMERICA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 28 NORTH AMERICA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 29 NORTH AMERICA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 30 NORTH AMERICA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 31 NORTH AMERICA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 32 NORTH AMERICA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 33 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 34 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 35 NORTH AMERICA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 36 NORTH AMERICA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 37 NORTH AMERICA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 38 NORTH AMERICA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 39 NORTH AMERICA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 40 NORTH AMERICA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 41 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 42 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 43 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 44 NORTH AMERICA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 45 NORTH AMERICA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 46 NORTH AMERICA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 47 NORTH AMERICA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 48 NORTH AMERICA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 49 NORTH AMERICA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 50 NORTH AMERICA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 51 NORTH AMERICA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 52 NORTH AMERICA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 53 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 54 NORTH AMERICA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 55 NORTH AMERICA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 56 NORTH AMERICA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 57 NORTH AMERICA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 58 NORTH AMERICA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 59 NORTH AMERICA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 60 NORTH AMERICA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 61 NORTH AMERICA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 62 NORTH AMERICA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 63 NORTH AMERICA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 64 NORTH AMERICA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 65 NORTH AMERICA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 66 NORTH AMERICA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 67 NORTH AMERICA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 68 NORTH AMERICA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 69 NORTH AMERICA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 70 NORTH AMERICA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 71 NORTH AMERICA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 72 NORTH AMERICA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 73 NORTH AMERICA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 74 NORTH AMERICA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 75 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 76 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 77 NORTH AMERICA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 78 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 79 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 80 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 81 NORTH AMERICA SYNTHETIC NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 82 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 83 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 84 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 85 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 86 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 87 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 88 NORTH AMERICA DIRECT TENDER IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 89 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 90 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 91 NORTH AMERICA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 92 NORTH AMERICA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 93 NORTH AMERICA OTHERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY REGION, 2024-2032 (USD THOUSAND)

TABLE 94 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 95 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRODUCT, 2024-2032 (USD THOUSAND)

TABLE 96 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 97 NORTH AMERICA NUCLEIC ACID SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 98 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY COUNTRY, 2024-2032 (USD THOUSAND)

TABLE 99 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 100 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 101 NORTH AMERICA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 102 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 103 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 104 NORTH AMERICA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 105 NORTH AMERICA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 106 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 107 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 108 NORTH AMERICA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 109 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 110 NORTH AMERICA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 111 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 112 NORTH AMERICA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 113 NORTH AMERICA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 114 NORTH AMERICA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 115 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 116 NORTH AMERICA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 117 NORTH AMERICA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 118 NORTH AMERICA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 119 NORTH AMERICA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 120 NORTH AMERICA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 121 NORTH AMERICA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 122 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 123 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 124 NORTH AMERICA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 125 NORTH AMERICA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 126 NORTH AMERICA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 127 NORTH AMERICA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 128 NORTH AMERICA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 129 NORTH AMERICA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 130 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 131 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 132 NORTH AMERICA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 133 NORTH AMERICA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 134 NORTH AMERICA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 135 NORTH AMERICA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 136 NORTH AMERICA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 137 NORTH AMERICA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 138 NORTH AMERICA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 139 NORTH AMERICA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 140 NORTH AMERICA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 141 NORTH AMERICA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 142 NORTH AMERICA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 143 NORTH AMERICA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 144 NORTH AMERICA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 145 NORTH AMERICA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 146 NORTH AMERICA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 147 NORTH AMERICA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 148 NORTH AMERICA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 149 NORTH AMERICA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 150 NORTH AMERICA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 151 NORTH AMERICA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 152 NORTH AMERICA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 153 NORTH AMERICA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 154 NORTH AMERICA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 155 NORTH AMERICA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 156 NORTH AMERICA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 157 NORTH AMERICA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 158 NORTH AMERICA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 159 NORTH AMERICA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 160 NORTH AMERICA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 161 NORTH AMERICA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 162 NORTH AMERICA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 163 NORTH AMERICA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 164 NORTH AMERICA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 165 NORTH AMERICA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 166 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 167 NORTH AMERICA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 168 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 169 NORTH AMERICA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 170 NORTH AMERICA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 171 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 172 NORTH AMERICA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 173 NORTH AMERICA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 174 NORTH AMERICA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 175 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 176 U.S. ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 177 U.S. ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 178 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 179 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 180 U.S. RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 181 U.S. CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 182 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 183 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 184 U.S. MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 185 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 186 U.S. NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 187 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 188 U.S. DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 189 U.S. DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 190 U.S. DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 191 U.S. DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 192 U.S. DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 193 U.S. DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 194 U.S. RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 195 U.S. RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 196 U.S. RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 197 U.S. GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 198 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 199 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 200 U.S. BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 201 U.S. TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 202 U.S. DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 203 U.S. JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 204 U.S. AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 205 U.S. SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 206 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 207 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 208 U.S. NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 209 U.S. MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 210 U.S. DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 211 U.S. LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 212 U.S. SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 213 U.S. SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 214 U.S. POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 215 U.S. CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 216 U.S. DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 217 U.S. UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 218 U.S. DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 219 U.S. AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 220 U.S. BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 221 U.S. ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 222 U.S. DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 223 U.S. RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 224 U.S. HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 225 U.S. OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 226 U.S. HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 227 U.S. DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 228 U.S. UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 229 U.S. MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 230 U.S. POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 231 U.S. ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 232 U.S. COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 233 U.S. SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 234 U.S. FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 235 U.S. DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 236 U.S. SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 237 U.S. SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 238 U.S. HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 239 U.S. ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 240 U.S. NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 241 U.S. SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 242 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 243 U.S. NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 244 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 245 U.S. INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 246 U.S. PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 247 U.S. NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 248 U.S. RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 249 U.S. STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 250 U.S. NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 251 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 252 CANADA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 253 CANADA ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 254 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 255 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 256 CANADA RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 257 CANADA CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 258 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 259 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 260 CANADA MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 261 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 262 CANADA NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 263 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 264 CANADA DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 265 CANADA DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 266 CANADA DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 267 CANADA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 268 CANADA DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 269 CANADA DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 270 CANADA RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 271 CANADA RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 272 CANADA RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 273 CANADA GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 274 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 275 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 276 CANADA BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 277 CANADA TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 278 CANADA DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 279 CANADA JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 280 CANADA AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 281 CANADA SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 282 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 283 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 284 CANADA NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 285 CANADA MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 286 CANADA DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 287 CANADA LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 288 CANADA SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 289 CANADA SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 290 CANADA POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 291 CANADA CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 292 CANADA DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 293 CANADA UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 294 CANADA DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 295 CANADA AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 296 CANADA BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 297 CANADA ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 298 CANADA DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 299 CANADA RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 300 CANADA HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 301 CANADA OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 302 CANADA HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 303 CANADA DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 304 CANADA UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 305 CANADA MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 306 CANADA POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 307 CANADA ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 308 CANADA COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 309 CANADA SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 310 CANADA FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 311 CANADA DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 312 CANADA SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 313 CANADA SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 314 CANADA HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 315 CANADA ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 316 CANADA NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 317 CANADA SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 318 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 319 CANADA NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 320 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 321 CANADA INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 322 CANADA PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 323 CANADA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 324 CANADA RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 325 CANADA STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 326 CANADA NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 327 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY CATEGORY, 2024-2032 (USD THOUSAND)

TABLE 328 MEXICO ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 329 MEXICO ANTISENSE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 330 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY MOLECULES, 2024-2032 (USD THOUSAND)

TABLE 331 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUGS, 2024-2032 (USD THOUSAND)

TABLE 332 MEXICO RNA INTERFERENCE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 333 MEXICO CPG OLIGONUCLEOTIDES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 334 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY STRUCTURE, 2024-2032 (USD THOUSAND)

TABLE 335 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DRUG TYPE, 2024-2032 (USD THOUSAND)

TABLE 336 MEXICO MARKETED/APPROVED DRUGS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 337 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 338 MEXICO NUCLEIC ACID THERAPEUTICS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY ROUTE OF ADMINISTRATION, 2024-2032 (USD THOUSAND)

TABLE 339 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 340 MEXICO DNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 341 MEXICO DNA REPAIR SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 342 MEXICO DNA-INFUSED MOISTURIZERS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 343 MEXICO DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 344 MEXICO DNA-BASED FACE MASKS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 345 MEXICO DNA-INFUSED EYE CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 346 MEXICO RNA-BASED SKIN CARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 347 MEXICO RNA-INFUSED CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 348 MEXICO RNA-BASED ANTI-AGING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 349 MEXICO GENE THERAPY-INFUSED SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 350 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SKIN TYPE, 2024-2032 (USD THOUSAND)

TABLE 351 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING, 2024-2032 (USD THOUSAND)

TABLE 352 MEXICO BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 353 MEXICO TUBES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 354 MEXICO DROPPER BOTTLES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 355 MEXICO JARS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 356 MEXICO AMPOULES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 357 MEXICO SACHETS AND POUCHES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 358 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PACKAGING SIZE, 2024-2032 (USD THOUSAND)

TABLE 359 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY PRICE RANGE, 2024-2032 (USD THOUSAND)

TABLE 360 MEXICO NUCLEIC ACID SKIN CARE PRODUCTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 361 MEXICO MOISTURIZATION & HYDRATION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 362 MEXICO DEEP HYDRATION WITH NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 363 MEXICO LONG-LASTING HYDRATION SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 364 MEXICO SKIN BARRIER STRENGTHENING IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 365 MEXICO SKIN REGENERATION & REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 366 MEXICO POST-SURGERY & INTENSIVE HEALING TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 367 MEXICO CELLULAR RENEWAL TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 368 MEXICO DNA DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 369 MEXICO UV PROTECTION & SUN DAMAGE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 370 MEXICO DNA-BASED SUNSCREENS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 371 MEXICO AFTER-SUN DNA REPAIR TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 372 MEXICO BLUE LIGHT & POLLUTION PROTECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 373 MEXICO ACNE & SCAR TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 374 MEXICO DNA-BASED ACNE CONTROL SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 375 MEXICO RNA-POWERED SCAR FADING CREAMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 376 MEXICO HORMONAL ACNE TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 377 MEXICO OIL-CONTROL & PORE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 378 MEXICO HYPERPIGMENTATION & DARK SPOT TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 379 MEXICO DARK SPOT CORRECTORS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 380 MEXICO UNEVEN SKIN TONE CORRECTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 381 MEXICO MELANIN-INHIBITING SERUMS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 382 MEXICO POST-INFLAMMATORY HYPERPIGMENTATION (PIH) TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 383 MEXICO ANTI-AGING & WRINKLE REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 384 MEXICO COLLAGEN-BOOSTING FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 385 MEXICO SKIN FIRMING & ELASTICITY IMPROVEMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 386 MEXICO FINE LINE TREATMENT IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 387 MEXICO DEEP WRINKLE REPAIR IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 388 MEXICO SENSITIVE SKIN CARE & INFLAMMATION REDUCTION IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 389 MEXICO SOOTHING & ANTI-REDNESS FORMULATIONS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 390 MEXICO HYPOALLERGENIC DNA-BASED SKINCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 391 MEXICO ANTI-INFLAMMATORY NUCLEIC ACID TREATMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 392 MEXICO NUCLEIC ACID SPORTS FOOD ADDITIVES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY APPLICATION, 2024-2032 (USD THOUSAND)

TABLE 393 MEXICO SPORTS SUPPLEMENTS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 394 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY SOURCE, 2024-2032 (USD THOUSAND)

TABLE 395 MEXICO NATURAL NUCLEIC ACIDS IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 396 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY END USER, 2024-2032 (USD THOUSAND)

TABLE 397 MEXICO INDIVIDUAL CONSUMERS/ HOME HEALTHCARE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 398 MEXICO PROFESSIONAL/FACILITY USE IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 399 MEXICO NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY DISTRIBUTION CHANNEL, 2024-2032 (USD THOUSAND)

TABLE 400 MEXICO RETAIL SALES IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 401 MEXICO STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

TABLE 402 MEXICO NON STORE BASED IN NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET, BY TYPE, 2024-2032 (USD THOUSAND)

Lista de Figura

FIGURE 1 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET

FIGURE 2 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DATA TRIANGULATION

FIGURE 3 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DROC ANALYSIS

FIGURE 4 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS

FIGURE 5 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: MULTIVARIATE MODELLING

FIGURE 7 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 8 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 NORTH AMERICA SPORT FOOD ADDITIVES AND SKIN CARE MARKET: DBMR MARKET POSITION GRID

FIGURE 10 NORTH AMERICA NUCLEIC ACID THERAPEUTICS,

FIGURE 11 SPORT FOOD ADDITIVES AND SKIN CARE MARKET

FIGURE 12 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: END USER COVERAGE GRID

FIGURE 13 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: END USER COVERAGE GRID

FIGURE 14 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: SEGMENTATION

FIGURE 15 GROWING DEMAND FOR FUNCTIONAL FOODS, NUTRACEUTICALS, AND BIOACTIVE SKINCARE INGREDIENTS IS EXPECTED TO DRIVE THE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET IN THE FORECAST PERIOD

FIGURE 16 THE NUCLEIC ACID THERAPEUTICS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET IN 2025 AND 2032

FIGURE 17 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: EXECUTIVE SUMMARY

FIGURE 18 STRATEGIC DECISIONS

FIGURE 19 PORTER’S FIVE FORCES

FIGURE 20 IMPORT EXPORT SCENARIO (USD THOUSAND)

FIGURE 21 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET, 2024-2032, AVERAGE SELLING PRICE (USD/KG)

FIGURE 22 PATENT ANALYSIS BY COUNTRY

FIGURE 23 PATENT ANALYSIS BY COMPANY

FIGURE 24 NUMBER OF PATENT BY YEAR

FIGURE 25 DROC ANALYSIS

FIGURE 26 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY PRODUCT, 2024

FIGURE 27 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY SOURCE, 2024

FIGURE 28 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY END USER, 2024

FIGURE 29 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: BY DISTRIBUTION CHANNEL, 2024

FIGURE 30 NORTH AMERICA NUCLEIC ACID THERAPEUTICS, SPORT FOOD ADDITIVES AND SKIN CARE MARKET: SNAPSHOT, 2024

FIGURE 31 NORTH AMERICA NUCLEIC ACID THERAPEUTICS MARKET: COMPANY SHARE 2024 (%)

FIGURE 32 NORTH AMERICA NUCLEIC ACID SPORT FOOD ADDITIVES AND SKIN CARE MARKET: COMPANY SHARE, 2024 (%)

View Detailed Information

Metodologia de Investigação

A recolha de dados e a análise do ano base são feitas através de módulos de recolha de dados com amostras grandes. A etapa inclui a obtenção de informações de mercado ou dados relacionados através de diversas fontes e estratégias. Inclui examinar e planear antecipadamente todos os dados adquiridos no passado. Da mesma forma, envolve o exame de inconsistências de informação observadas em diferentes fontes de informação. Os dados de mercado são analisados e estimados utilizando modelos estatísticos e coerentes de mercado. Além disso, a análise da quota de mercado e a análise das principais tendências são os principais fatores de sucesso no relatório de mercado. Para saber mais, solicite uma chamada de analista ou abra a sua consulta.

A principal metodologia de investigação utilizada pela equipa de investigação do DBMR é a triangulação de dados que envolve a mineração de dados, a análise do impacto das variáveis de dados no mercado e a validação primária (especialista do setor). Os modelos de dados incluem grelha de posicionamento de fornecedores, análise da linha de tempo do mercado, visão geral e guia de mercado, grelha de posicionamento da empresa, análise de patentes, análise de preços, análise da quota de mercado da empresa, normas de medição, análise global versus regional e de participação dos fornecedores. Para saber mais sobre a metodologia de investigação, faça uma consulta para falar com os nossos especialistas do setor.

Personalização disponível

A Data Bridge Market Research é líder em investigação formativa avançada. Orgulhamo-nos de servir os nossos clientes novos e existentes com dados e análises que correspondem e atendem aos seus objetivos. O relatório pode ser personalizado para incluir análise de tendências de preços de marcas-alvo, compreensão do mercado para países adicionais (solicite a lista de países), dados de resultados de ensaios clínicos, revisão de literatura, mercado remodelado e análise de base de produtos . A análise de mercado dos concorrentes-alvo pode ser analisada desde análises baseadas em tecnologia até estratégias de carteira de mercado. Podemos adicionar quantos concorrentes necessitar de dados no formato e estilo de dados que procura. A nossa equipa de analistas também pode fornecer dados em tabelas dinâmicas de ficheiros Excel em bruto (livro de factos) ou pode ajudá-lo a criar apresentações a partir dos conjuntos de dados disponíveis no relatório.

Perguntas frequentes

Quais são os principais segmentos abordados no relatório Relatório de análise do tamanho, quota e tendências do mercado?

O mercado é segmentado com base em Segmentação do mercado de ácido nucleico terapêutico, aditivos alimentares para desporto e cuidados com a pele na América do Norte, por produto (ácido nucleico terapêutico, produtos de ácido nucleico para cuidados com a pele e aditivos alimentares de ácido nucleico para desporto), fonte (ácidos nucleicos naturais e ácidos nucleicos sintéticos), utilizador final (consumidores individuais/saúde domiciliária e utilização profissional/em instalações), canal de distribuição (licitação direta, vendas a retalho e outros) - tendências do setor e previsão até 2032 .

Qual é o tamanho atual do mercado de Relatório de análise do tamanho, quota e tendências do mercado?

O tamanho do Relatório de análise do tamanho, quota e tendências do mercado foi avaliado em USD 5.50 USD Billion no ano de 2024.

Qual é a taxa de crescimento esperada para Relatório de análise do tamanho, quota e tendências do mercado?

O Relatório de análise do tamanho, quota e tendências do mercado está projetado para crescer a um CAGR de 7.14% durante o período de previsão de 2025 a 2032.

Quem são os principais players do Relatório de análise do tamanho, quota e tendências do mercado?

Os principais players do mercado incluem Pfizer Inc., Biogen, Alnylam Pharmaceuticals Inc., Ionis Pharmaceuticals Inc.,AstraZeneca.

Relatório de análise do tamanho, quota e tendências do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele na América do Norte – Visão geral e previsão do setor até 2032

Contorne os desafios das tarifas com uma consultoria ágil da cadeia de abastecimento

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

CAGR : 7.14 %

Tamanho do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Análise de mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Âmbito de mercado das terapêuticas com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

Participação no mercado de produtos terapêuticos com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

Últimos desenvolvimentos no mercado da terapêutica com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

Relatórios

Informações de mercado

Apoiar

Soluções

Relatório de análise do tamanho, quota e tendências do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele na América do Norte – Visão geral e previsão do setor até 2032

Contorne os desafios das tarifas com uma consultoria ágil da cadeia de abastecimento

North America Nucleic Acid Therapeutics Sport Food Additives And Skin Care Market

CAGR : 7.14 %

Tamanho do mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Análise de mercado de terapêuticas com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Âmbito de mercado das terapêuticas com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

Participação no mercado de produtos terapêuticos com ácido nucleico, aditivos alimentares desportivos e cuidados com a pele

Últimos desenvolvimentos no mercado da terapêutica com ácidos nucleicos, aditivos alimentares desportivos e cuidados com a pele

Obtenha acesso online ao relatório sobre a primeira nuvem de inteligência de mercado do mundo

Índice

Lista de Tabela

Lista de Figura

Metodologia de Investigação

Personalização disponível

Perguntas frequentes

Navegue pelas páginas relacionadas